Acne Treating Drug, Zanatane, Launched in US Market by Dr Reddy's Laboratories

Drug firm Dr Reddy's Laboratories has received the approval from USFDA for its drug Zanatane capsules and has launched the drug in the US market.

The capsules available in the strengths of 10 mg, 20 mg and 40 mg and in boxes of 30 are used to treat severe form of acne namely, severe recalcitrant nodular acne.

The capsules are generic version of Accutane (Isotretinoin Capsules USP) of Hoffman- La Roche Inc.

This launch has hiked the value of the company's shares.

Source: Medindia